20th International Conference on Cellular and Molecular Medicine is scheduled on October 14-15 of 2019, at Rome, Italy.
Molecular Medicine 2019 is enlightened with a theme: "Advancements in cellular and Molecular medicine” provides a distinguished platform for all the Participants around the globe to enlighten the subject and the developments.
Molecular medicine invites all the delegates across the world to take part in the conference and make the way for a successful conference. Cellular and Molecular Medicine 2019 mainly focuses on the developing trends and advances in the field of Molecular Medicine, Cellular Medicine and its allied research areas.
“Cellular and Molecular Medicine conference” provides a valuable platform to discuss and learn about
- Cellular and Molecular Medicine
- Molecular Drug Designing
- Medical diagnosis
- Cellular medicine
- Stem cell Biology
- Molecular and Cellular Aspects in Diabetes
- Nuclear Medicine & Molecular Imaging:
- Tissue Engineering
- Pathology & Immunotherapy
- Clinical and Translational Research
- Biochemistry and Molecular Biology
- Molecular Virology
- Molecular pathology
- Department of Molecular Medicine
- Department of Cell and Tissue Engineering
- Clinical Researchers, Professors, Associate Professors, Assistant Professors
- Ph.D. Scholars, Graduates and Post Graduates
- Directors, CEO’s of Organizations
- Association Presidents, Vice Presidents, and Professionals
- Noble laureates in Health Care and Medicine
- Pharmaceutical development companies
- Research Institutes and members
- Medical devices Manufacturing Companies
- Training Institutes
- Business Entrepreneurs
- All accepted abstracts will be published in the respective International supporting Journals
- Each abstract will receive a (DOI) Number provided by CrossRef
- All attendees will receive individual certification
- Special privileges on group registrations
- Networking with Experts in the Field
- Live Streaming of your presentation through our websites and YouTube
- Best Poster Competitions and Young Researcher Competitions among students all over the world
- The Career Guidance Workshops to the Graduates, Doctorates and Post-Doctoral Fellows
- Chance of B2B meeting
- Opportunity to organize Workshop/Symposia
- Opportunity to collaborate with our event
- Avail the opportunity to organize pre-conference workshop
- Individual momentous will be given to the Organizing Committee Members
- Appreciation momentous will be awarded to the Moderators
- Opportunity to interact with eminent personalities from all around the globe
- Handbook and conference kit
- 60% discount on manuscript publication
- Keynote presentations along with interactions to galvanize the scientific community.
- Workshop and symposiums to reach the largest assemblage of participants from the Cellular and Molecular Medicine Communities and Associations.
- A wide track of exhibitors to showcase new and emerging technologies.
- Platform to the global investment community to connect with stakeholders in the pharma sector.
- Young Scientist/ Investigators Award geared towards best budding young research.
- Links to political marketing resources in order to expand your business and research network.
- Triumph of Awards, Certificates recognizes your commitment to your profession to encourage nascent research.
Allied Academies is one of the leading organizers and Open access publishers of international scientific events and conferences every year across Europe, USA and Asia. Allied Academies has organized 3000+ worldwide Events with over, 600+ Conferences, 1200+ Symposiums, and 1200+ Workshops on pharmaceutical company, Engineering, Technology, Science, Medical and Business with 700+ peer-reviewed open access Journals in basic science, health, and technology.
Cellular and Molecular Medicine Conference is for the gathering of Professors, researchers, clinicians, students of medicines and pharmacy, business tycoons and technocrats to display their recent research and talk about new thoughts, improvement and progresses in the field of Cellular, Molecular Medicine, basic clinical research, pre-clinical research, Genetics, Tissue Engineering, advancement in treatment and diagnosis or relieving symptoms of diseases, present and future challenge of Cellular and Molecular Medicine, social and cultural aspect of Molecular Medicine Researches.
The molecular and cellular medicine portfolio focuses on basic biological mechanisms or technologies relevant to human health and disease, including understanding the aetiology of disease and developing treatments. This includes specific responsibility for the MRC’scancer research portfolio, including basic biology, epidemiology and early translational research. Encompasses all fundamental and molecular aspects of Medicine.
Drug design, frequently alluded to as reasonable medication outline or essentially normal plan, is the innovative procedure of finding new pharmaceuticals considering the information of a natural target. The medication is most generally a natural little atom that actuates or restrains the capacity of a bio molecule. for example, a protein, which thus brings about a remedialadvantage to the patient. In the most essential sense, medicate configuration includes the outline of particles that are corresponding fit as a fiddle and charge to the bio molecular focus with which they collaborate and in this way, will tie to it. Medication outline much of the time however not really depends on PC displaying systems.
It is the way toward figuring out which illness or condition clarifies a man's side effects and signs. It is frequently alluded to as determination with the restorative setting being certain. The data required for finding is commonly gathered from a history and physical examination of the individual looking for restorative care. Frequently, at least one analyticmethodology, for example, indicative tests, are likewise done amid the procedure. Once in a while after death finding is viewed as a sort of restorative analysis.
Cell Medicine is another logical idea presented by Dr. Matthias Rath which clarifies that the essential driver of the present most basic interminablemaladies including different types of cardiovascular infections, diabetes, disease, and others, is a consequence of constant inadequacy of vitamins, amino acids and other particular supplements.
At no other time was the inadequacy of cell bio-vitality and bio-strength portrayed as the essential driver of a whole gathering of infections.
Cell Medicine characterizes an ideal every day admission of particularmicronutrients as a fundamental protection measure for looking after wellbeing, and successful and safe control of numerous obsessive conditions.
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use
Stem cells are undifferentiated biological cells that have the potential to become specialized into different types of cells. Stem cell therapy can be used to prevent or cure several vital diseases like Parkinson’s disease, heart disease, spinal cord injury, etc. Stem Cell Medicine plans to play an active role in guiding and shaping the future of the pharmaceutical industry, now entering the era of personalized medical treatments. Customized medicine will largely depend on cell therapy and stem-cell combinations. Stem Cell Medicine intends to contribute significantly to the industry’s leap from current stem-cell R&D practices, technology and first-stage product development to pharmaceutical solutions.
Diabetes mellitus portrayed by hyperglycemia is a gathering of metabolic maladies caused by lopsided direction of the flagging falls that intervenes insulin activity in the phone, imperfection of insulin discharge or both. The insulin-like development factors (IGFs) and their receptors and restricting proteins constitute a group of cell modulators that assume basic parts in the control of development and improvement. The IGF ligands incorporate three fundamentally related peptides: insulin, IGF-I, and IGF-II.
Genes contain your DNA — the code that controls much of your body's form and function, from making you grow taller to regulating your body systems. Genes that don't work properly can cause disease.
Gene therapy replaces a faulty gene or adds a new gene in an attempt to cure disease or improve your body's ability to fight disease. Gene therapy holds promise for treating a wide range of diseases, such as cancer, cystic fibrosis, heart disease, diabetes, hemophilia and AIDS.
Researchers are still studying how and when to use gene therapy. Currently, in the United States, gene therapy is available only as part of a clinical trial.
Sub-atomic imaging is a kind of medicinal imaging that gives point by point pictures of what is going on inside the body at beams, figured tomography(CT) and ultrasound—offer pictures of physical structure, sub-atomic imaging enables doctors to perceive how the body is working and to quantify its synthetic and the sub-atomic and cell level. Where other indicative imaging systems, for example, x-organic procedures.
Tissue engineering is a rising multidisciplinary field that uses a blend of cells, building materials and biochemical elements to enhance or supplant natural capacities which thus enhance the wellbeing and personal satisfaction for many individuals worldwide by reestablishing, keeping up, or improving tissue and organ work. Tissue designing advanced from the field of biomaterials improvement and alludes to the act of consolidating platforms, cells, and organically dynamic particles into utilitarian tissues. The objective of tissue designing is to amass useful develops that reestablish, keep up, or enhance harmed tissues or entire organs. Fake skin and ligament are cases of designed tissues that have been affirmed by the FDA; notwithstanding, at present they have restricted use in human patients Tissue Engineering.
Metabolomics is the scientific study of chemical processes involving metabolites, the small molecule intermediates and products of metabolism. Specifically, metabolomics is the "systematic study of the unique chemical fingerprints that specific cellular processes leave behind", the study of their small-molecule metabolite profiles. The metabolome represents the complete set of metabolites in a biological cell, tissue, organ or organism, which are the end products of cellular processes. mRNA gene expression data and proteomic analyses reveal the set of gene products being produced in the cell, data that represents one aspect of cellular function. Conversely, metabolic profiling can give an instantaneous snapshot of the physiology of that cell, and thus, metabolomics provides a direct "functional readout of the physiological state" of an organism. One of the challenges of systems biology and functional genomics is to integrate genomics, transcriptomic, proteomic, and metabolomic information to provide a better understanding of cellular biology.
Pathology is a gigantic piece of the therapeutic sciences to appreciate the possibility of the disease and an imperative field in conclusion and present day remedy. It joins a broad assortment of restorative practices and bioscience research to investigate disease generally by separating cells, tissues and body fluids. Nuclear arrangement is a rising domain that way to understand the sub-nuclear determinants of ailment and prosperity for the neutralizingactivity, finding and treatment using physical, substance, common and therapeutic procedures. The Department of Pathology and Molecular Medicine is a clinical office with an imperative research focus in tumor, hemostasis and vascular science. Understudies thusly have opportunities to look for after sweeping planning in fundamental and translational biomedical research, a case being symptomatic, perceptive and prognostic biomarker explore. The graduate undertakings offer opportunities to look for in the wake of bleeding edge degrees under the supervision of a great social event of major, clinical and translational investigators.
Due to rapidly advancing field of cancer immunology in past few years, there has been production of several new methods of treating cancer called Immunotherapies. Immunotherapy is a type of treatment that increases the strength of immune response against tumors either by stimulating the activities of specific components of immune system or by counteracting signals produced by cancer cells that suppress immune responses. Some types of immunotherapy are also called as biologic therapy or biotherapy. Recent advancements in cancer immunotherapies have provided new therapeutic approaches. These include tumor-associated macrophages as treatment targets in oncology, in-situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy, immune checkpoint blockade and associated endocrinopathies and many more.
According to National Institute of Health (NIH), Clinical Research is defined in 3 ways i.e. (1) Patient oriented research. Research which is conducted with human subjects (or on material of human origin such as tissues, specimens and cognitive phenomena) for which an investigator (or colleague) directly interacts with human subjects. This definition excludes the in vitro studies that utilize human tissues that cannot be linked to a living individual. Patient oriented research involves: (a) therapeutic interventions, (b) mechanisms of human disease, (c) clinical trials, or (d) development of new technologies. (2) Epidemiological and behavioural investigations. (3) Outcomes research and health services research.
Biochemistry is the study of the structure and function of biologicalmolecules such as proteins, nucleic acids, carbohydrates and lipids. Biochemistry is also used to describe techniques suited to understanding the interactions and functions of biological molecules and it is a laboratory based science that brings together biology and chemistry. By using chemical knowledge and techniques, biochemists can understand and solve biological problems. Biochemistry focuses on processes happening at a molecular level and it focuses on what’s happening inside our cells. It also looks at how cells communicate with each other, for example during growth or fighting illness. Medicine is a broad category but relates to biochemistry on many levels. Doctors and nurses give drugs to patients to help cure a disease or prevent it. This is since when that drug is added to the human system, it alters how other chemicals in the body function, resulting in disease prevention or recovery.
The mission of the Molecular Virology is to facilitate the acquisition of new insights into virus biology and cellular function through the study of viruses and to develop novel approaches
An effective immune response can eliminate most viruses from the body and thus most viral infections are short lived. However, there are certain viruses that can evade the immune response and establish persistent infections in their host. The most famous example of such a virus is HIV, but there are many others. Viruses use a variety of strategies to evade the immune system. overall, these persistent infections are asymptomatic and only manifest clinically if the patient becomes immuno-compromised.to inhibit viral infection or treat viral diseases.
Molecular pathology is an emerging discipline within pathology which is focused in the study and diagnosis of disease through the examination of molecules within organs, tissues or bodily fluids. Molecular pathology shares some aspects of practice with both anatomic pathology and clinical pathology, molecular biology, biochemistry, proteomics and genetics, and is sometimes considered a "crossover" discipline. It is multi-disciplinary in nature and focuses mainly on the sub-microscopic aspects of disease. A key consideration is that more accurate diagnosis is possible when the diagnosis is based on both the morphologic changes in tissues (traditional anatomicpathology) and on molecular testing.
Importance and Scope:
“Stem Cell Research and Regenerative Medicine” is an important field since human development takes place through stem cells. The complete understanding of their unique properties and control mechanisms can give an insight into early human development. Metabolic or physiological diseases such as cancer are thought to result from the abnormal behavior of cells. This means that a clear understanding of where things go 'wrong' in stem cell division can give a clear picture about cancer and can aid in realizing the ways to prevent the dysfunctional changes in the body or to introduce effective ways to treat them with targeted drugs. Stem cell application in regenerative medicine and tissue engineering is an alternative therapy for various diseases and the on-going extensive research in this field is assumed to further steer the medical applications of stem cells in upcoming years.
It accounted for the highest share in industrial development once they participate nationwide or geographically within the field of producing regenerative medicines. When we look into the geographic distribution of tissue engineering companies and research institutes, the U.S.A with 52 leads the market followed by Germany (21%), Japan (16%), the United Kingdom (7%), and Sweden (4%).
The global tissue engineering and regeneration market reached $17 billion in 2013. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, a compound annual growth rate (CAGR) of 22.3%.
Today’s Market Study of Tissue Engineering and Regenerative Medicine in USA, Europe, Middle East and Asia Pacific
USA: The global regenerative medicine market size is predicted to reach USD 49.41 billion by the year 2021.North America contributed the biggest share in the worldwide regenerative medicines market and was overwhelmed by the U.S.A.
Europe: The worldwide tissue engineering and regeneration market came to $17 billion in 2013. This market is anticipated to grow to almost $20.8 billion in 2014 and $56.9 billion in 2019.
Middle East: The Middle East and Africa regenerative medicines market is expected to achieve USD 5.75 billion by 2021 from USD 2.03 billion in 2016, developing at a CAGR of 23.15% amid the estimate time frame 2016-2021. Regenerative medicines repair, replace or regenerate human cells, tissues, or organs affected due to injury, aging processes, congenital defects, and damage due to trauma.
Asia-Pacific: Asia-Pacific regenerative medicines market is relied upon to achieve UUSD 10.71 billion by 2021 from USD 3.01 billion in 2016, developing at a CAGR of 28.90% during the time period 2016-2021. Cell-based products sector is estimated to account for larger share of Asia-Pacific regenerative medicines market by product in 2016.
Tissue Science is expected to be the fastest emerging technology because of the tremendous potential of gene therapy in minimizing immune rejections, which commonly occur after transplantations. Asia-Pacific would be the fastest growing region for regenerative medicine market. Europe and North America together accounted for over 3/4th of the market revenue and anticipated to be a most profitable regional market.
Worldwide Tissue Science Societies:
- Australasian Society for Biomaterials and Tissue Engineering
- European Society for Artificial Organs
- European Association of Tissue Banks
- German Society of Anti-Aging Medicine
- International Federation for Artificial Organs
- Tissue Engineering and Regenerative Medicine International Society
- American Academy of Anti-Aging Medicine
- Tissue and Cell Engineering Society (TCES)
- Korean Tissue Engineering and Regenerative Medicine Society
- Japanese Society for Tissue Engineering
STEM CELLS MARKET OVERVIEW
Globally Regenerative Medicines market size is predicted to reach USD 30,237 million by 2022. Recently, regenerative Medicine has emerged with full of promise approaches to treat and cure complex degenerative disorder and to support, restore the function of tissues and cells in other therapies. North America lead the way of global market in 2015 and it is expected to remain ascendant during 2015-2022. Stem Cells are used to treat cancer and different immune system diseases.